|  | 
  
  
 Vaccine Detail
                          
                            | RCN-F1-V (Yersinia pestis F1 and V) |  
                            | Vaccine Information |  
                            | 
							  Vaccine Name: RCN-F1-V (Yersinia pestis F1 and V)Target Pathogen: Yersinia pestisTarget Disease: PlagueVaccine Ontology ID: VO_0004692Type: Recombinant vector vaccineStatus: ResearchHost Species for Licensed Use: BaboonVector: raccoon poxvirus vaccine vector
                            
						Preparation: Recombinant raccoon poxvirus (RCN) expressing plague antigens (fraction 1 [F1] and a truncated form of the V protein-V307) (Rocke et al., 2010).Immunization Route: Intramuscular injection (i.m.) |  
                            | Host Response |  
                            | Dog Response 
                              Host Strain: black-tailed prairie dogs (Cynomys ludovicianus)Vaccination Protocol: Voluntary consumption of baits expressing plague antigens several times over the course of several months to a group of 16 black-tailed prairie dogs. Another group of prairie dogs was injected subcutaneously (SC) (prime and boost) with 40 microg of F1-V fusion protein absorbed to alum, a vaccine-adjuvant combination demonstrated to elicit immunity to plague in mice and other mammals. Control animals received baits containing RCN without the inserted antigen or injected diluent (Rocke et al., 2010).Vaccine Immune Response Type: VO_0003057Challenge Protocol: Three weeks after consumption of the final vaccine-laden bait and 10 weeks after the injectable vaccine administration, animals were challenged with the CO92 wild-type isolate of Y. pestis (provided by USAMRIID), a highly virulent and well- characterized strain (Rocke et al., 2010).Efficacy: The oral vaccination of prairie dogs using RCN-based plague vaccines provided significant protection against challenge at dosages that simulate simultaneous delivery of the plague bacterium by numerous flea bites. |  
                  | References |  
                            |  |  |